Clinical Trial Update: Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin as second-line therapy for Non-Hodgkin l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• METHYLPREDNISOLONE (methylprednisolone)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Asan Medical Center | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2010-06-22